Published in J Neuropathol Exp Neurol on October 01, 2003
Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology (2012) 1.64
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol (2006) 1.21
Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2009) 1.18
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol Neurosurg Psychiatry (2005) 1.16
Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis. Am J Pathol (2008) 1.11
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics (2007) 1.09
Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol (2011) 0.96
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol (2013) 0.92
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis. Front Cell Neurosci (2013) 0.90
Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol (2014) 0.88
The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol (2013) 0.86
Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways. Curr Genomics (2012) 0.84
Maturation of the GABAergic transmission in normal and pathologic motoneurons. Neural Plast (2011) 0.81
Enhancement of single motor unit inhibitory responses to transcranial magnetic stimulation in amyotrophic lateral sclerosis. Exp Brain Res (2008) 0.78
Reduction in focal ictal activity following transplantation of MGE interneurons requires expression of the GABAA receptor α4 subunit. Front Cell Neurosci (2015) 0.76
Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS. Sci Rep (2017) 0.75
Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports (2017) 0.75
Motor Alterations Induced by Chronic 4-Aminopyridine Infusion in the Spinal Cord In vivo: Role of Glutamate and GABA Receptors. Front Neurosci (2016) 0.75
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett (2003) 1.71
Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol (2009) 1.56
A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy. Ann Neurol (2006) 1.55
Transition metal abnormalities in progressive dementias. Biometals (2011) 1.51
Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med (2008) 1.51
Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol (2004) 1.47
Absence of pestivirus antigen in brains with white matter damage. Dev Med Child Neurol (2006) 1.39
Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci (2009) 1.26
ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci (2008) 1.22
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol (2006) 1.21
Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke (2011) 1.18
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol (2008) 1.17
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol (2009) 1.10
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One (2012) 1.09
Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol Dis (2005) 1.08
Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 1.05
The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum Mol Genet (2011) 1.04
Repetitive transcranial magnetic stimulation for the treatment of chronic pain - a pilot study. Eur Neurol (2002) 1.03
Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem (2002) 1.01
Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. Eur J Neurosci (2003) 1.01
Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler (2007) 1.01
Increased intracortical inhibition in middle-aged humans; a study using paired-pulse transcranial magnetic stimulation. Neurosci Lett (2002) 1.01
Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum Brain Mapp (2011) 1.01
Valproic acid promotes neurite outgrowth in PC12 cells independent from regulation of the survival of motoneuron protein. Chem Biol Drug Des (2006) 1.00
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res (2010) 1.00
Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2008) 0.99
Comparative study of cell culture and purification methods to obtain highly enriched cultures of proliferating adult rat Schwann cells. J Neurosci Res (2004) 0.99
Faster nerve regeneration after sciatic nerve injury in mice over-expressing basic fibroblast growth factor. J Neurobiol (2006) 0.99
Intertemporal choice in Parkinson's disease. Mov Disord (2011) 0.99
Human and rat adult Schwann cell cultures: fast and efficient enrichment and highly effective non-viral transfection protocol. Nat Protoc (2007) 0.99
Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci (2012) 0.99
Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain (2006) 0.98
Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP. Muscle Nerve (2013) 0.97
Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing. Eur J Neurosci (2002) 0.97
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci (2009) 0.96
Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis (2012) 0.96
Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures. J Neural Transm (Vienna) (2015) 0.95
Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy. Eur J Neurosci (2005) 0.95
On emotional conflict: interference resolution of happy and angry prosody reveals valence-specific effects. Cereb Cortex (2009) 0.95
Needle acupuncture in chronic poststroke leg spasticity. Arch Phys Med Rehabil (2004) 0.94
Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat alpha(1)beta(2)gamma(2S) GABA(A) receptor channels. Eur J Pharmacol (2002) 0.94
Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.93
Chitosan tubes of varying degrees of acetylation for bridging peripheral nerve defects. Biomaterials (2013) 0.93
Gene therapy in peripheral nerve reconstruction approaches. Curr Gene Ther (2007) 0.93
Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells (2006) 0.93
Treatment of phantom limb pain with botulinum toxin type A. Pain Med (2009) 0.93
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging (2002) 0.92
Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve (2011) 0.92
Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2010) 0.91
Schimke immuno-osseous dysplasia: a clinicopathological correlation. J Med Genet (2006) 0.91
Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler (2008) 0.91
Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: comparison of binding to non-phosphorylated and phosphorylated VEGFR2. Bioorg Med Chem (2011) 0.90
Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve (2006) 0.90
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function. Pharmacology (2009) 0.90
The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus. FASEB J (2007) 0.90
Evaluation of periodic electrodiagnostic measurements to monitor motor recovery after different peripheral nerve lesions in the rat. Muscle Nerve (2011) 0.89
Perception of emotional speech in Parkinson's disease. Mov Disord (2006) 0.89
Rat embryonic motoneurons in long-term co-culture with Schwann cells--a system to investigate motoneuron diseases on a cellular level in vitro. J Neurosci Methods (2005) 0.89
Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol (2012) 0.89
Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence. Pharmacogenet Genomics (2005) 0.89
Genetically modified canine Schwann cells--In vitro and in vivo evaluation of their suitability for peripheral nerve tissue engineering. J Neurosci Methods (2009) 0.89
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem (2010) 0.89
Changes in resting-state brain networks in writer's cramp. Hum Brain Mapp (2011) 0.89
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. Mol Cancer (2013) 0.88
Biochemical characterization of TAK-593, a novel VEGFR/PDGFR inhibitor with a two-step slow binding mechanism. Biochemistry (2011) 0.88
Block of voltage-operated sodium channels by 2,6-dimethylphenol, a structural analogue of lidocaine's aromatic tail. Br J Pharmacol (2002) 0.88
Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol (2004) 0.88
Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke (2013) 0.88
Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord (2010) 0.88
Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. J Neural Transm (Vienna) (2014) 0.88
The effects of FGF-2 gene therapy combined with voluntary exercise on axonal regeneration across peripheral nerve gaps. Neurosci Lett (2008) 0.87
Diffraction-enhanced X-ray imaging under low-temperature conditions: non-destructive observations of clathrate gas hydrates. J Synchrotron Radiat (2012) 0.87
Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry. Anal Bioanal Chem (2011) 0.87
Disturbed egocentric space representation in cervical dystonia. Mov Disord (2005) 0.87
Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J Neuropathol Exp Neurol (2012) 0.87